Prostate Cancer, Version 3.2024-Reference-Cited by-同舟云学术

Prostate Cancer, Version 3.2024

Published:2024-04 Issue:3 Volume:22 Page:140-150
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Schaeffer Edward M.¹,Srinivas Sandy²,Adra Nabil³,An Yi⁴,Bitting Rhonda⁵,Chapin Brian⁶,Cheng Heather H.⁷,D’Amico Anthony Victor⁸,Desai Neil⁹,Dorff Tanya¹⁰,Eastham James A.¹¹,Farrington Thomas A.¹²,Gao Xin¹³,Gupta Shilpa¹⁴,Guzzo Thomas¹⁵,Ippolito Joseph E.¹⁶,Karnes R. Jeffrey¹⁷,Kuettel Michael R.¹⁸,Lang Joshua M.¹⁹,Lotan Tamara²⁰,McKay Rana R.²¹,Morgan Todd²²,Pow-Sang Julio M.²³,Reiter Robert²⁴,Roach Mack²⁵,Robin Tyler²⁶,Rosenfeld Stan²⁷,Shabsigh Ahmad²⁸,Spratt Daniel¹⁴,Szmulewitz Russell²⁹,Teply Benjamin A.³⁰,Tward Jonathan³¹,Valicenti Richard³²,Wong Jessica Karen³³,Snedeker Jenna³⁴,Freedman-Cass Deborah A.³⁴

Affiliation:

1. Robert H. Lurie Comprehensive Cancer Center of Northwestern University

2. Stanford Cancer Institute

3. Indiana University Melvin and Bren Simon Comprehensive Cancer Center

4. Yale Cancer Center/Smilow Cancer Hospital

5. Duke Cancer Institute

6. The University of Texas MD Anderson Cancer Center

7. Fred Hutchinson Cancer Center

8. Dana-Farber/Brigham and Women's Cancer Center

9. UT Southwestern Simmons Comprehensive Cancer Center

10. City of Hope National Cancer Center

11. Memorial Sloan Kettering Cancer Center

12. Prostate Health Education Network (PHEN)

13. Mass General Cancer Center

14. Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

15. Abramson Cancer Center at The University of Pennsylvania

16. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

17. Mayo Clinic Comprehensive Cancer Center

18. Roswell Park Comprehensive Cancer Center

19. University of Wisconsin Carbone Cancer Center

20. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

21. UC San Diego Moores Cancer Center

22. University of Michigan Rogel Cancer Center

23. Moffitt Cancer Center

24. UCLA Jonsson Comprehensive Cancer Center

25. UCSF Helen Diller Family Comprehensive Cancer Center

26. University of Colorado Cancer Center

27. University of California San Francisco Patient Services Committee

28. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

29. The UChicago Medicine Comprehensive Cancer Center

30. Fred & Pamela Buffett Cancer Center

31. Huntsman Cancer Institute at the University of Utah

32. UC Davis Comprehensive Cancer Center

33. Fox Chase Cancer Center

34. National Comprehensive Cancer Network

Abstract

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.

Publisher

Harborside Press, LLC

Link

https://jnccn.org/downloadpdf/journals/jnccn/22/3/article-p140.xml

Reference39 articles.

1. Cancer statistics, 2024;Siegel RL,2024

2. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era;D’Amico AV,2002

3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico AV,1998

4. Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy;Tom MC,2020

5. International multicenter validation of an intermediate risk subclassification of prostate cancer managed with radical treatment without hormone therapy;Berlin A,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies;European Journal of Medicinal Chemistry;2024-12

2. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

3. Efficacy and safety evaluation of androgen deprivation therapy-based combinations for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis;British Journal of Cancer;2024-09-02

4. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

5. A global view of the challenges and limitations of precision medicine for genitourinary cancers;Urologic Oncology: Seminars and Original Investigations;2024-08